Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04493138
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2020-07-27
Brief Title:
Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or MyelodysplasticMyeloproliferative Neoplasm With FLT3 or CBL Mutations
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Myeloproliferative Neoplasm |
| Chronic Myelomonocytic Leukemia |
| Myelodysplastic Syndrome |
| Myeloproliferative Neoplasm |
| Recurrent Chronic Myelomonocytic Leukemia |
| Recurrent Myelodysplastic Syndrome |
Keywords: